HCA Healthcare, Inc.
HCA · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.86 | -13.67 | -1.28 | 0.13 |
| FCF Yield | 7.26% | 6.36% | 5.92% | 6.48% |
| EV / EBITDA | 8.70 | 9.01 | 8.20 | 8.33 |
| Quality | ||||
| ROIC | 16.68% | 16.42% | 16.66% | 18.18% |
| Gross Margin | 14.94% | 14.82% | 15.03% | 16.47% |
| Cash Conversion Ratio | 1.58 | 1.80 | 1.25 | 1.16 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.44% | 3.41% | 5.34% | 4.60% |
| Free Cash Flow Growth | 20.31% | 13.57% | -23.32% | -15.87% |
| Safety | ||||
| Net Debt / EBITDA | 3.12 | 3.22 | 2.96 | 2.48 |
| Interest Coverage | 5.12 | 4.97 | 5.21 | 6.33 |
| Efficiency | ||||
| Inventory Turnover | 34.55 | 27.38 | 24.75 | 24.71 |
| Cash Conversion Cycle | 40.15 | 41.36 | 38.39 | 34.49 |